NMR crystallography of oxybuprocaine hydrochloride, Modification II degrees.
about
Differences in Dynamics between Crosslinked and Non-Crosslinked Hyaluronates Measured by using Fast Field-Cycling Relaxometry.Structural, thermoanalytical and molecular modeling studies on N-(3-hydroxypropyl) 3 alpha,12 alpha-dihydroxy-5 beta-cholan-24-amide and its monohydrates.Applications of solid-state NMR to pharmaceutical polymorphism and related matters.Rapid analysis of organic compounds by proton-detected heteronuclear correlation NMR spectroscopy with 40 kHz magic-angle spinning.Calculation of NMR parameters in ionic solids by an improved self-consistent embedded cluster method.Does Z' equal 1 or 2? Enhanced powder NMR crystallography verification of a disordered room temperature crystal structure of a p38 inhibitor for chronic obstructive pulmonary disease.Polymorphs of Theophylline Characterized by DNP Enhanced Solid-State NMR.Testing the limits of sensitivity in a solid-state structural investigation by combined X-ray powder diffraction, solid-state NMR, and molecular modelling.Powder crystallography of pharmaceutical materials by combined crystal structure prediction and solid-state 1H NMR spectroscopy.Unexpected effects of third-order cross-terms in heteronuclear spin systems under simultaneous radio-frequency irradiation and magic-angle spinning NMR.Near-Ideal Xylene Selectivity in Adaptive Molecular Pillar[ n]arene Crystals.Solid‐State NMR Studies of Pharmaceutical SystemsSolid-State NMR Applications in the Structural Elucidation of Small MoleculesNMR crystallography on paramagnetic systems: solved and open issues
P2860
Q30986725-1F147614-8EAA-4A4F-A745-E602FF193919Q31134314-C2744278-392D-4D4B-ABA0-88C546ACDA43Q36725317-CD0A045B-4E5E-4DAD-AB80-82111A914595Q37362168-86A4171D-317F-4242-8DCA-CD39AAA65A86Q37672364-8230D6F3-501D-4C30-9E95-CDDE6D94B355Q38722695-F842CF1D-D1E5-4E79-9294-8B19EE61D1AAQ41290111-1998D030-0F02-4864-8D5F-DC20FF0FD3E2Q45376567-B5B6E883-0EF5-4A89-94E5-5009B0870EBBQ48025876-B6BC97CB-048D-4553-945A-D74F3C12C195Q51411802-CD02AB15-D076-4CA1-942A-88E5A626E52DQ55257878-E5A459BD-B6A1-4814-8BA0-6AD9A5CF777DQ57348567-B66EADFA-AE2E-40DB-96CF-7A51BA21819DQ57651136-D2C1C4CC-BECF-46D9-A6A2-D81FA4A1DE38Q58619052-1B6C91FC-848F-4023-8133-2834B5624952
P2860
NMR crystallography of oxybuprocaine hydrochloride, Modification II degrees.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
NMR crystallography of oxybuprocaine hydrochloride, Modification II degrees.
@en
NMR crystallography of oxybuprocaine hydrochloride, Modification II degrees.
@nl
type
label
NMR crystallography of oxybuprocaine hydrochloride, Modification II degrees.
@en
NMR crystallography of oxybuprocaine hydrochloride, Modification II degrees.
@nl
prefLabel
NMR crystallography of oxybuprocaine hydrochloride, Modification II degrees.
@en
NMR crystallography of oxybuprocaine hydrochloride, Modification II degrees.
@nl
P2093
P2860
P50
P356
P1476
NMR crystallography of oxybuprocaine hydrochloride, Modification II degrees.
@en
P2093
Jonathan R Yates
Ram K R Jetti
Robin K Harris
Sylvian Cadars
P2860
P304
P356
10.1039/B614318K
P407
P577
2006-11-24T00:00:00Z